ReviewReviews in cardiovascular medicine2026
Acetylcholine Provocation Testing for Coronary Vasomotor Disorders.
Review in Reviews in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vasospastic angina and microvascular angina are increasingly recognized as important causes of myocardial ischemia in patients with angina or myocardial infarction and non-obstructive coronary arteries (ANOCA/MINOCA). Unlike obstructive coronary artery disease, these conditions result from dynamic alterations in epicardial and/or microvascular tone that are not detected by standard coronary angiography. Intracoronary acetylcholine (ACh) provocation testing enables direct assessment of coronary vasomotor function by evaluating both endothelial integrity and smooth muscle reactivity. Moreover, ACh can identify epicardial spasm, microvascular spasm, or impaired endothelium-dependent vasodilation, thereby providing precise characterization of the underlying pathophysiological mechanism. When performed using standardized protocols, ACh testing has shown a high diagnostic yield and a reassuring safety profile. In addition to the associated diagnostic relevance, the ACh response carries prognostic significance, as abnormal findings are associated with a higher risk of recurrent angina and adverse cardiovascular events. Furthermore, randomized data demonstrated that treatment tailored to invasive coronary function testing improves symptoms and quality of life. This review summarizes the pathophysiological background, practical aspects, safety, and clinical value of ACh provocation testing, underscoring its central role in a more personalized approach to patients with ANOCA/MINOCA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.